Compare AJANTA PHARMA with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ALEMBIC PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA ALEMBIC PHARMA AJANTA PHARMA/
ALEMBIC PHARMA
 
P/E (TTM) x 23.5 15.3 153.1% View Chart
P/BV x 4.1 3.5 117.3% View Chart
Dividend Yield % 0.9 1.1 78.8%  

Financials

 AJANTA PHARMA   ALEMBIC PHARMA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
ALEMBIC PHARMA
Mar-19
AJANTA PHARMA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs1,422664 214.1%   
Low Rs898412 217.7%   
Sales per share (Unadj.) Rs233.5208.7 111.9%  
Earnings per share (Unadj.) Rs44.031.0 141.8%  
Cash flow per share (Unadj.) Rs52.237.1 140.5%  
Dividends per share (Unadj.) Rs9.005.50 163.6%  
Dividend yield (eoy) %0.81.0 75.9%  
Book value per share (Unadj.) Rs255.1144.2 176.9%  
Shares outstanding (eoy) m88.02188.52 46.7%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x5.02.6 192.6%   
Avg P/E ratio x26.417.4 151.9%  
P/CF ratio (eoy) x22.214.5 153.3%  
Price / Book Value ratio x4.53.7 121.8%  
Dividend payout %20.517.7 115.4%   
Avg Mkt Cap Rs m102,081101,461 100.6%   
No. of employees `0006.8NA-   
Total wages/salary Rs m4,3077,467 57.7%   
Avg. sales/employee Rs Th3,022.6NM-  
Avg. wages/employee Rs Th633.4NM-  
Avg. net profit/employee Rs Th569.1NM-  
INCOME DATA
Net Sales Rs m20,55439,347 52.2%  
Other income Rs m21194 224.7%   
Total revenues Rs m20,76539,441 52.6%   
Gross profit Rs m5,6648,736 64.8%  
Depreciation Rs m7211,152 62.6%   
Interest Rs m12184 6.3%   
Profit before tax Rs m5,1437,493 68.6%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-93 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,2731,568 81.2%   
Profit after tax Rs m3,8705,844 66.2%  
Gross profit margin %27.622.2 124.1%  
Effective tax rate %24.820.9 118.3%   
Net profit margin %18.814.9 126.8%  
BALANCE SHEET DATA
Current assets Rs m11,81219,577 60.3%   
Current liabilities Rs m3,77614,896 25.4%   
Net working cap to sales %39.111.9 328.6%  
Current ratio x3.11.3 238.0%  
Inventory Days Days7790 86.2%  
Debtors Days Days8245 179.9%  
Net fixed assets Rs m14,39827,097 53.1%   
Share capital Rs m175377 46.5%   
"Free" reserves Rs m22,27726,811 83.1%   
Net worth Rs m22,45227,188 82.6%   
Long term debt Rs m74,993 0.1%   
Total assets Rs m26,96247,778 56.4%  
Interest coverage x444.341.7 1,065.5%   
Debt to equity ratio x00.2 0.2%  
Sales to assets ratio x0.80.8 92.6%   
Return on assets %14.412.6 114.1%  
Return on equity %17.221.5 80.2%  
Return on capital %23.023.6 97.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m10,68219,453 54.9%   
Fx outflow Rs m2,1026,065 34.7%   
Net fx Rs m8,58013,388 64.1%   
CASH FLOW
From Operations Rs m3,7488,120 46.2%  
From Investments Rs m-2,228-7,556 29.5%  
From Financial Activity Rs m-1,475590 -249.8%  
Net Cashflow Rs m451,153 3.9%  

Share Holding

Indian Promoters % 73.8 74.1 99.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 2.9 53.4%  
FIIs % 7.6 9.1 83.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 13.9 122.3%  
Shareholders   20,968 49,328 42.5%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   ALEMBIC LTD  SUN PHARMA  PIRAMAL ENTERPRISES  FDC LTD.  SHASUN PHARMA  

Compare AJANTA PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Over 100 Points Down; Banking and IT Stocks Under Pressure(09:30 am)

Asian share markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.9% while the Hang Seng is also down 0.9%.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 8.4% (Quarterly Result Update)

Aug 2, 2019 | Updated on Aug 2, 2019

For the quarter ended June 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 8.4% YoY). Sales on the other hand came in at Rs 6 bn (up 19.8% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9% (Quarterly Result Update)

May 9, 2019 | Updated on May 9, 2019

For the quarter ended March 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.6% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Sep 17, 2019 09:51 AM

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS